Silence Therapeutics (OTCMKTS:SLNCF) Shares Up 3.2% – What’s Next?

Silence Therapeutics plc (OTCMKTS:SLNCFGet Free Report)’s share price rose 3.2% on Thursday . The stock traded as high as $5.78 and last traded at $5.78. Approximately 100 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 1,541 shares. The stock had previously closed at $5.60.

Silence Therapeutics Price Performance

The firm has a 50 day moving average of $6.14 and a two-hundred day moving average of $6.78.

About Silence Therapeutics

(Get Free Report)

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.

See Also

Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.